Top Causes of Mortality Worldwide Projected to 2020 in New Espicom Study Available at MarketPublishers.com

New research study “Global Causes of Death to 2020” drawn up by Espicom Business Intelligence has been recently published by Market Publishers Ltd. It is expected, as the study reports, that by 2020-end, the mortality rate per 100,000 population will fall globally in such key conditions as breast cancer and respiratory diseases.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
TD The Market Publishers Ltd

http://marketpublishers.com/

London, UK (PRWEB) June 21, 2012

There are lots of complex reasons lying behind the shifting outlook for the cause of mortality rates worldwide. For the more developed countries, the ageing population evidently plays a prominent role, with circulatory diseases and neoplasms accounting for the majority of deaths, but as healthcare technology and lifestyle improvements start to impact related mortality, then other causes of death related to longevity become more prevalent. As far as less developed countries are concerned, healthcare technology and health information may be less obtainable. This in turn can result in increased incidence of deaths stemming from preventable or treatable diseases like circulatory disease, cancer and diabetes.

It is expected that by 2020-end, the mortality rate per 100,000 population will fall globally in such key conditions as breast cancer and respiratory diseases.

New research study “Global Causes of Death to 2020” drawn up by Espicom Business Intelligence has been recently published by Market Publishers Ltd.

Report Details:

Title: Global Causes of Death to 2020
Published: May, 2012
Pages: 284
Price: US$ 2,265.00
http://marketpublishers.com/report/social_researches/social_studies/global_causes_of_death_to_2020.html

The research study offers an in-depth discussion of the leading causes of death throughout the world, comprising:

  •     analysis of trends in 23 diseases/conditions as well as forecasts of patient population growth with data covering 2012-2020;
  •     evaluation of the current and future patient profile by cause of death by 55 leading and emerging markets;
  •     assessment at global and country level;
  •     ranking of cause of death globally and identification of areas of increasing need;
  •     original forecast data.

Report Contents:

Overview

Financial Review

2011 Financial Results
Wound Care
Surgical Products
Employees

Strategic Focus

Products

Surgical Products
Wound Care Products

Research and Development

Manufacturing

Agreements

Novation
DSV
Premier
Synvasive Technology (Zimmer)
Consorta
Kuehne + Nagel
HealthTrust Purchasing Group
Broadlane/MedAssets
UPS Logistics Group
Biora
D Logistics
Innovatix

Mergers and Acquisitions

Brennen Medical
Rynel
JKT
PharmaSet
Mölnlycke Trade Mark
Thai Klinipro
Johnson & Johnson’s Barrier Brand

Divestitures

Irish Manufacturing Facility
First Aid Business
Ortman
Feminine, Consumer and Incontinence Business Units

Litigation

Brightwake
Smith & Nephew
Kinetic Concepts
Dumex Medical Surgical Products

Key Corporate Events

List of Tables

Summary Operating Results
Recent Key Events
Mölnlycke Health Care - Annual Financial Data, 2008-2011
Mölnlycke Health Care - Manufacturing Facilities
Agreements Summary
Mergers and Acquisitions Summary
Mölnlycke Health Care - Key Corporate Events

List of Charts

Mölnlycke Health Care – Annual Sales and EBITDA, 2008-2011
Mölnlycke Health Care - Sales by Business Area, 2011
Mölnlycke Health Care - Sales by Geographic Area, 2011

More new research studies by the publisher can be found at Espicom Business Intelligence page.


Contact